Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 8631-8640 of 13616

Page
per page
  1. NE 52-QQ57
    A9921 NE 52-QQ57
    Summary: A selective oral G-protein-coupled receptor 4 (GPR4) antagonist
      ≥10.2 mg/mL
  2. Fmoc-B-HoPhe-OH
    BA9325 Fmoc-B-HoPhe-OH
    Summary: A phenylalanine derivative.
  3. Anacardic acid
    A4488 Anacardic acid
     1 Citation
    Target: Histone Acetyltransferases (HATs)
    Summary: HAT inhibitor
      insoluble in H2O; ≥17.45 mg/mL
  4. Erlotinib Hydrochloride
    A8234 Erlotinib Hydrochloride
     2 Citation
    Summary: Selective EGFR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥6.44 mg/mL
  5. SKLB610
    A8237 SKLB610
    Summary: Potent VEGFR inhibitor
      insoluble in H2O; ≥20.75 mg/mL
  6. ZSTK474
    A8248 ZSTK474
    Summary: Potent PI3K inhibitor
      insoluble in H2O; insoluble in EtOH; ≥20.85 mg/mL
  7. Sulfasalazine
    A5770 Sulfasalazine
    Summary: NF-κB activation inhibitor
      insoluble in ETOH; insoluble in H2O; ≥17.7 mg/mL
  8. Dinaciclib (SCH727965)
    A8412 Dinaciclib (SCH727965)
     6 Citation
    Target: Cyclin-Dependent Kinases
    Summary: Potent CDK inhibitor
  9. Acyclovir
    A8644 Acyclovir
     2 Citation
    Target: HSV
    Summary: Antiviral agent
      insoluble in H2O; insoluble in EtOH; ≥11.4 mg/mL
  10. ME0328
    A8808 ME0328
    Target: PARP
    Summary: PARP inhibitor,potent and selective
      ≥71.43 mg/mL

Items 8631-8640 of 13616

Page
per page